| CLA1687 |
|
2382896-07-1 |
西貝瑞單抗
Sibeprenlimab (Synonyms: VIS649)
-
95+%
|
需詢價(jià) |
— |
|
|
|
| HL1801 |
|
27028-76-8 |
|
需詢價(jià) |
C39H63NO11 |
|
|
|
| CL1815B |
|
150374-95-1 |
西維來司鈉
Sivelestat Sodium Anhydrous | ONO5046-Na | Sodium sivelestat | EI546 sodium | LY544349 sodium
-
98+%
|
需詢價(jià) |
C20H21N2NaO7S |
|
|
|
| CL2688 |
|
1191237-69-0 |
GS-441524
GS-441524
-
98+%
|
需詢價(jià) |
C12H13N5O4 |
|
|
|
| HL1486 |
|
65995-63-3 |
安石榴苷
Punicalagin
3-5days
98+%
|
￥1000.00 |
C48H28O30 |
|
|
|
| HL1134 |
|
65666-07-1 |
|
需詢價(jià) |
C25H22O10 |
|
|
|
| CL1431 |
|
2628280-40-8 |
(1R,2S,5S)-N-((S)-1-氰基2-((S)-2-氧代吡咯烷-3-基)乙基)-3-((S)-3,3-二甲基-2-(2,2,2-三氟乙酰胺基)丁?；?-6,6-二甲基-3-氮雜雙環(huán)[3.1.0]己烷-2-甲酰胺; 奈瑪特韋
Nirmatrelvir (Synonyms: PF-07321332)
In-stock
Purity: 99.26%
|
￥306.00 |
C23H32F3N5O4 |
|
|
|
| CL1439 |
|
1809249-37-3 |
((S)-(((2R,3S,4R,5R)-5-(4-氨基吡咯[2,1-f][1,2,4]三嗪-7-基)-5-氰基-3,4-二羥四氫呋喃-2-基)甲氧基)(苯氧基)磷?；?-L-丙氨酸-2-乙基丁基醇酯; 瑞德西韋; 倫地西韋
Remdesivir (Synonyms: GS-5734)
In-stock
Purity: 99.75%
|
￥306.00 |
C27H35N6O8P |
|
|
|
| CL1059A |
|
2757470-18-9 |
恩斯特韋富馬酸鹽 | 恩賽特韋富馬酸鹽
Ensitrelvir fumarate(S-217622)
-
98+%
|
需詢價(jià) |
C22H17ClF3N9O2.C4H4O4 |
|
|
|
| CL1059 |
|
2647530-73-0 |
恩賽特韋
Ensitrelvir | S-217622
-
99+%
|
需詢價(jià) |
C22H17ClF3N9O2 |
|
|
|
| CL1056 |
|
2349386-89-4 |
(2R,3S,4R,5R)-3,4-二羥基-5-[4-(羥基氨基)-2-惡吡啶-1-基]惡唑烷-2-基]甲基2-甲基丙酸鹽; 莫匹拉韋
Molnupiravir (Synonyms: EIDD-2801; MK-4482)
In-stock
Purity: 99.84%
|
￥168.00 |
C13H19N3O7 |
|
|
|
| CL1054 |
|
91188-00-0 |
1-乙基-7-(3-((乙基氨基)甲基)吡咯烷-1-基)-6,8-二氟-4-氧代-1,4-二氫喹啉-3-羧酸
Merafloxacin | CI-934
-
98+%
|
需詢價(jià) |
C19H23F2N3O3 |
|
|
|
| CL1815 |
|
127373-66-4 |
西維來司他
Sivelestat | EI546 | LY544349 | ONO5046
-
98+%
|
需詢價(jià) |
C20H22N2O7S |
|
|
|
| CL1815A |
|
201677-61-4 |
西維來司鈉四水合物 | 西維來司他鈉
Sivelestat Sodium Tetrahydrate | EI546 sodium tetrahydrate | LY544349 sodium tetrahydrate | ONO5046 sodium tetrahydrate
-
98+%
|
需詢價(jià) |
C20H29N2NaO11S |
|
|
|
| CL2319A |
|
700361-47-3 |
鹽酸利匹韋林 | 利匹韋林鹽酸鹽
Rilpivirine Hydrochloride | TMC-278 hydrochloride
-
98+%
|
需詢價(jià) |
C22H19ClN6 |
|
|
|
